|
|
||||||||
1School of Kinesiology, Faculty of Health Sciences, 2Lawson Health Research Institute, The University of Western Ontario, London, Ontario; and 3Department of Chemistry and Biochemistry, Laurentian University, Sudbury, Ontario, Canada
Submitted 12 July 2005 ; accepted in final form 16 November 2005
| ABSTRACT |
|---|
|
|
|---|
compensatory overload; heat shock proteins; fiber types; thyroid hormone; fiber transformation
It is well established that muscles adapt to ongoing recruitment with a remodeling process, which results in the transcription and translation of isoforms of myofibrillar proteins metabolically suited for the imposed contractile demands (3). For instance, fast-to-slow type remodeling occurs following the increased contractile activity associated with compensatory overload, as evidenced by the increase in relative expression of MHC I (12, 27). This observation is noteworthy since expression of Hsp70 not only tends to parallel slower, more oxidative fiber-type gene expression in unstressed muscles (13, 22) but also during changes in expression of this gene program as a consequence of compensatory overload (12, 21, 23), clenbuterol-induced hypertrophy (24), or altered thyroid hormone status (12). More recently, it has been observed (22, 25) that the sudden and sustained increase of contractile activity in the developing rat is not accompanied by an immediate increase in Hsp70. Rather, increases in Hsp70 were correlated with developmentally regulated changes in slow phenotype expression. Hence, constitutive Hsp70 expression could be more closely aligned with fiber phenotype than fiber recruitment and loading.
To address these possibilities, we sought to 1) characterize the fiber type-specific expression of Hsp70 during the phenotypic transformation to a sustained increase in the frequency of contractile activity and 2) determine whether contractile activity or phenotypic remodeling is responsible for elevated Hsp70 content following this adaptation. It was hypothesized that Hsp70 content would only be altered in concert with changes in the slower muscle phenotype as exemplified by altered levels of MHC I.
| METHODS |
|---|
|
|
|---|
Compensatory overload. Rat PLT muscle was subjected to compensatory overload following removal of the gastrocnemius and soleus of each hindlimb (8). Animals were randomly assigned to control and overload groups. Overload muscles were harvested at 3 days and 1, 2, and 4 wk after synergistic ablation. These times were chosen so as to follow the time course of fiber-specific Hsp70 expression while separating the potential short-term effects of muscle damage, inflammation, and rapid growth (1, 9) from that observed at 4 wk, when a stable muscle phenotype has been established (9). Shorter term groups underwent surgery 2.5 wk later than the longer term groups, thereby allowing all muscles, including those from control animals, to be harvested at a similar age and body weight. Midsections of the PLT were mounted on a cork, quickly frozen in isopentane precooled with liquid nitrogen (for histochemical analysis), and subsequently stored as above until processing.
Hyperthyroidism and increased muscle use. In this model, PLT muscle was subjected to compensatory overload after removal of the ipsilateral gastrocnemius of one hindlimb only. The other hindlimb, which had been subjected to a similar hormonal milieu, served as a control (10). The day after surgery, animals were randomly assigned to thyroid hormone (T3; 300 µg/kg 3,5,3'-triiodo-DL-thyronine dissolved in 0.6 mM NaOH ip) and sham-injected (0.6 mM NaOH carrier solution) groups and received injections every second day over 40 days. This treatment period was the same as that employed by Ianuzzo et al. (10), and it also ensured that phenotypic changes in the overloaded muscle had stabilized before assessment (9). Although the molecular basis by which T3 alters muscle phenotype is not fully established, the combination of overload and T3 treatments enabled a selective increase in the contractile activity of the PLT while preventing the normal overload-induced changes in slow gene expression (10). At the end of the experimental period, both overloaded and contralateral control PLT muscles were harvested.
To address the possibility that T3 treatment had a direct and irreversible effect on Hsp70 induction, hyperthyroid rats were subjected to heat shock (H), an established inducer of Hsp70. Rats were injected every second day with either T3 or carrier solutions for 20 days [a point at which T3-induced changes in skeletal muscle have stabilized (18)]. Half the animals from each injection (T3H and H from hyperthyroid and control groups, respectively) group were lightly anesthetized with pentobarbital sodium (35 mg/kg ip) and wrapped in a heating blanket until rectal temperature reached 41.5°C, where it was maintained for 15 min. Twenty-four hours later, animals were fully anesthetized and PLT muscles were harvested.
Gel electrophoresis. Muscle samples weighing 50100 mg were homogenized in 19 volumes of 15 mM Tris (pH 7.5), 600 mM NaCl containing 1/200th volume each of 0.2 M phenylmethylsulfonyl fluoride in ethanol, 0.2 mg/ml pepstatin A in ethanol, and 0.1 mg/ml leupeptin in double-distilled H2O as protease inhibitors. During homogenization, samples were kept on ice and then centrifuged at 5,000 g for 10 min at 4°C, and the supernatant was stored at 80°C until analyses were performed. Proteins were quantified by the Lowry method (16), and one-dimensional SDS-PAGE was performed on muscle homogenates as described previously (12), except that the separating gel was 12% polyacrylamide.
Immunoblotting. Proteins were electrophoretically transferred (for a total of 200 V/h) to 0.2-µm pore size nitrocellulose membranes in 20% methanol-1.44% glycine buffer (pH 8.3) containing 0.1% SDS and 0.3% Tris·HCl. Transfer buffer temperature was maintained below 15°C by placing the transfer apparatus at 4°C. Membranes were then blocked overnight in a 5% skim milk powder solution in Tris-buffered saline (500 mM CaCl, 20 mM Tris·HCl pH 7.5), washed twice (5 min each) in Tris-buffered saline containing 0.5% Tween 20 (TTBS), and then reacted with primary antibodies specific for MHC I (anti-MHC I monoclonal antibody, 10D10; 1:750) or Hsp70 (anti-Hsp70 polyclonal antibody, StressGen SPA-812; 1:3,000) in TTBS with 2% skim milk powder for 2 h. After two washes of 5 min each in TTBS, membranes were reacted with secondary antibodies [goat-anti-mouse and goat-anti-rabbit alkaline-phosphatase (Bio-Rad) conjugated for the MHC I and Hsp70 blots, respectively] at 1:1,000 dilutions in TTBS with 2% skim milk powder for 2 h. After washes of 5 min each in TTBS and Tris-buffered saline, blots were transferred to 100 ml of bicarbonate buffer (100 mM NaCO3, 1 mM MgCl2) containing 1 ml each of 3% (wt/vol) p-nitro blue tetrazolium chloride p-toluidine salt in 70% (wt/vol) N,N-dimethylformamide and 1.5% (wt/vol) 5-bromo-4-chloro-3-indolyl phosphate in 100% N,N-dimethylformamide to visualize the protein bands. After color development (210 min), blots were rinsed in two changes of a large volume of water and placed between filter paper to dry. Blots were scanned and quantified using the Scion Image (National Institutes of Health) analysis system. Data for both Hsp70 and MHC I were then corrected relative to a standard of pooled soleus (obtained from 8- to 11-wk-old male rats) and normalized to the appropriate control, set as 100%. Individual gels contained samples from each experimental group used in the analysis.
Immunohistochemistry. Serial tissue cross sections (10 µm) from the muscle midbelly were cut at 20°C using a cryostat (Reichart-Jung, Heidelberg, Germany), adhered to microscope slides and placed within a humidified chamber. Hsp70 was detected using methods described previously (4). Briefly, tissues were fixed using cold neutral buffered formalin (pH 7.4) for 2 min and rinsed in (2 x 10 min for all washes unless otherwise noted) washes with cold 25 mM PBS (pH 7.6). Tissues were then permeablized with 0.3% Triton-X in PBS for 10 min, followed by PBS washes. Tissues were incubated for 1 h in a blocking solution consisting of 5% goat serum (Sigma, St. Louis, MO) in a carrier solution consisting of 0.5% bovine serum albumin in PBS. Sections were subsequently incubated for 4 h at 4°C in carrier solution with a Hsp70 inducible-specific polyclonal antibody (1:200; SPA-812, StressGen, Victoria, BC, Canada). Sections were rinsed with PBS (3 x 10 min) and incubated at 4°C in peroxidase-conjugated goat anti-rabbit immunoglobin G (1:500). After another PBS rinse, the bound antibodies were visualized using diaminobenzidine as a chromogen (4). For serial sections stained for detection of MHC isoforms, tissues were treated at room temperature and underwent a similar procedure with the following exceptions: tissues were not fixed or permeablized; tissues were incubated for 1 h in working dilutions of mouse or rat monoclonal antibodies raised against MHC I (BA-F8), IIa (SC-71), IIx, and IIb (212F), all isoforms except IIx (BF-35) and IIb (BF-F3); and tissues were incubated with a goat anti-mouse secondary at room temperature. Tissues were mounted with Permount (Fisher, Toronto, Canada).
The fiber-type composition of each muscle (n = 45/time point) was determined as follows (4): fibers were randomly chosen from within five distinct areas of each tissue midbelly section; all fibers (n > 400/section) were identified with the aid of a microscope linked to a computer-based image-analysis system; fibers were classified according to their staining profile, and fiber proportions were calculated for each muscle (I, IIa, IIx, fibers expressing MHC I, IIa, or IIx, respectively; I/IIa, IIa/IIx, fibers coexpressing MHC I and IIa or IIa and IIx, respectively; IIx/IIb, fibers expressing MHC IIb alone or coexpressing MHC IIb and IIx). After fiber-type classification of MHC isoform, a staining intensity score was derived from the average pixel density for encircled fibers on images of sections incubated with anti-Hsp70. Intensity of Hsp70 was reported in arbitrary linear (grayscale) units that were the result of subtracting background (primary antibody excluded) from positive (primary antibody included) serial sections. Microscope settings and conditions were held constant during capture of images of background and Hsp70 stains.
Statistical analyses. All data are expressed as means ± SE. Body weight, serum T3, heart weight, and heart weight-to-body weight ratios were compared by unpaired t-test. Comparisons among time points within a fiber type or among fiber types within a time point, during the adaptation to overload, were made using a one-way ANOVA. With muscle overload or heating and T3 protocols, muscle weight and protein data were compared using a two-way ANOVA. On determination of significant interactions, pairwise post hoc comparisons employing Tukey's test were used to determine differences between experimental groups. When tests of significance were made between specific groups, the Bonferroni correction for multiple comparisons was used. Differences were considered significant at P values of <0.05.
| RESULTS |
|---|
|
|
|---|
|
|
67 vs. 69% increase in muscle mass, respectively; Table 3).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
Constitutive expression of Hsp70 is fiber specific. The constitutive expression of Hsp70 in slow-type skeletal muscle has been suggested to be related to the frequent loading of these muscles (7, 13, 21). Although ongoing contractile activity has been associated with increased levels of Hsp70 (12, 2023, 25) the critical factor(s) linking these two observations have not been clear. To first characterize the adaptation to sustained contractile activity, the fiber-specific expression of Hsp70 during compensatory overload was examined. Using an objective, quantitative immunohistochemical approach, a distinct pattern of expression was observed during this remodeling process. Expression of Hsp70 was restricted to the smallest-caliber and thus most-recruited fiber types (types expressing MHC I and IIa) at all time points (3 days to 4 wk), including control conditions (day 0). These data are thus similar to those reported by Neufer et al. (20) in control rabbit tibialis anterior muscle but in contrast to the observations of Ogata et al. (22) who reported that Hsp70 was found only in type I fibers in the rat PLT. To determine whether differences in the present study vs. that of Ogata et al. (22) were a function of the rat species (Wistar vs. Sprague-Dawley) or Hsp70 antibody [monoclonal (StressGen SPA-810) vs. polyclonal (SPA-812)] employed, additional experiments were performed. Imunohistochemistry was conducted on cross sections of PLT muscle from groups of 8-wk-old male Wistar and Sprague-Dawley rats (n = 5 per strain) using the monoclonal Hsp70 antibody (StressGen SPA-810) employed by Ogata et al. (22). In our hands, this monoclonal antibody also revealed constitutive expression of Hsp70 in both type I and IIa fibers in each rat strain (Fig. 3). The reason(s) for the discrepancy between these data and those of Ogata et al. (22) remain unexplained. However, in agreement with previous observations in rabbit tibialis anterior (20), the present results, employing two different rat models and Hsp70-specific antibodies, clearly demonstrate that Hsp70 is not only present in fibers expressing both MHC I and/or IIa but actually tends to exhibit higher levels in type IIa fibers (Fig. 1B).
|
A reasonable interpretation of the data would be that a threshold level of contractile activity is required for the induction of Hsp70 (17) and that the necessary recruitment was only achieved by those fibers expressing MHC I and IIa. Indeed, these fibers underwent the greatest degree of hypertrophy. However, the extent to which the shift from fast to slow phenotype or maintenance of a slow phenotype, in the presence of contractile activity, contributed to the overall change in Hsp70 content was unclear. Because earlier observations suggest that muscle phenotype could be important (12, 13, 21, 22, 24, 25), we sought to test this hypothesis by separating the effect of increased contractile activity from phenotypic transformation.
Phenotypic transformation is critical for increased expression of Hsp70 following 40 days of compensatory overload. Despite a dramatic increase in contractile stress in overloaded muscle, 40 days of T3 treatment was able to suppress the shift toward a slower phenotype with increased Hsp70 (Table 3; Fig. 2). These data are similar to those recently reported by others (21) and suggest that interrupting signaling pathways, which are normally activated following contractile activity, results in specific consequences for Hsp70 expression. For example, signals leading to muscle hypertrophy may not require Hsp70 expression (it is never required in certain fiber types; see Fig. 1B), since overloaded muscles in the T3 group underwent a similar degree of hypertrophy as controls with no increase in Hsp70 expression (Table 3). Similar observations were made when muscle hypertrophy was induced with 4 wk of clenbuterol treatment (24). In the latter case, soleus hypertrophied by 16%, yet Hsp70 content was actually reduced by 52% (24). Also, in the developing diaphragm, the sudden onset of contractile activity coupled with a high rate of growth does not result in an increase in Hsp70 expression until myosin has begun to shift to a slower phenotype (25). However, in the present investigation, we cannot exclude that Hsp70 may have been upregulated early in the hypertrophic process and returned to control levels by 40 days. Indeed, in young animals, it has been observed that after only 2 wk of overload, T3 treatment reduced but did not completely suppress an overload-associated increase in Hsp70 (21). Nonetheless, these data suggest that slower phenotype remodeling may be a critical factor linking sustained contractile activity to elevated constitutive levels of Hsp70.
It should be noted that, under certain circumstances, changes in contractile activity can alter Hsp70 expression independent of phenotypic remodeling. For example, exercise training is known to elevate Hsp70, yet this change is not consistently accompanied by a parallel change in MHC I expression (11). In addition, Ornatsky and coworkers (26) reported an increase in Hsp70 following chronic low-frequency stimulation and no change in MHC I expression. However, chronic low-frequency stimulation eventually upregulates slow-type gene expression, and the discordant responses may represent differences in timing rather than regulation. The discrepancy between observations in the above studies and those of the present investigation may also be a consequence of multiple regulatory pathways influencing Hsp70 expression. For example, exercise may increase Hsp70 expression by directly activating the typical stress response pathway involving HSF1 (14). This pathway is also likely responsible for the elevated Hsp70 in PLT following heat shock (Fig. 3). However, other regulatory pathways must also be involved in elevated constitutive expression of Hsp70, since this protein is found at high levels in the unstressed rodent soleus without concomitant HSF1 activation (15). Since Hsp70 is known to modulate various transcription factors and mitogenic pathways (6), perhaps Hsp70 is a necessary component of the pathway(s) responsible for induction of the slower fiber phenotype(s).
In summary, we note fiber type-specific (type I and IIa fibers) expression of Hsp70 under control conditions as well as during adaptation to increased contractile activity. The mechanism underlying this restricted expression appears to be related to fast-to-slow phenotypic remodelling rather than a response to contractile activity per se. Indeed, by 40 days of overload at least, slower phenotype expression was critical to the increase in Hsp70 in muscles undergoing chronic contractile activity. Although some work in this regard has been initiated (21, 23, 24) future research should strive to elucidate the molecular signals and physiological importance underlying this intriguing relationship.
| GRANTS |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
E. Bombardier, C. Vigna, S. Iqbal, P. M. Tiidus, and A. R. Tupling Effects of ovarian sex hormones and downhill running on fiber-type-specific HSP70 expression in rat soleus J Appl Physiol, June 1, 2009; 106(6): 2009 - 2015. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Huey and B. M. Meador Contribution of IL-6 to the Hsp72, Hsp25, and {alpha}{beta}-crystallin responses to inflammation and exercise training in mouse skeletal and cardiac muscle J Appl Physiol, December 1, 2008; 105(6): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Huey, R. R. Roy, H. Zhong, and C. Lullo Time-dependent changes in caspase-3 activity and heat shock protein 25 after spinal cord transection in adult rats Exp Physiol, March 1, 2008; 93(3): 415 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Tupling, E. Bombardier, R. D. Stewart, C. Vigna, and A. E. Aqui Muscle fiber type-specific response of Hsp70 expression in human quadriceps following acute isometric exercise J Appl Physiol, December 1, 2007; 103(6): 2105 - 2111. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Huey, G. E. McCall, H. Zhong, and R. R. Roy Modulation of HSP25 and TNF-{alpha} during the early stages of functional overload of a rat slow and fast muscle J Appl Physiol, June 1, 2007; 102(6): 2307 - 2314. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |